HUP0001014A2 - Gasztrointesztinális lipáz inhibitorok felhasználása - Google Patents

Gasztrointesztinális lipáz inhibitorok felhasználása

Info

Publication number
HUP0001014A2
HUP0001014A2 HU0001014A HUP0001014A HUP0001014A2 HU P0001014 A2 HUP0001014 A2 HU P0001014A2 HU 0001014 A HU0001014 A HU 0001014A HU P0001014 A HUP0001014 A HU P0001014A HU P0001014 A2 HUP0001014 A2 HU P0001014A2
Authority
HU
Hungary
Prior art keywords
gastrointestinal lipase
lipase inhibitors
medicinal preparations
gastrointestinal
inhibitorsii
Prior art date
Application number
HU0001014A
Other languages
English (en)
Inventor
Jonathan Brian Hauptman
Original Assignee
F.Hoffmann-La Roche Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21894047&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0001014(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F.Hoffmann-La Roche Ag. filed Critical F.Hoffmann-La Roche Ag.
Publication of HUP0001014A2 publication Critical patent/HUP0001014A2/hu
Publication of HUP0001014A3 publication Critical patent/HUP0001014A3/hu
Publication of HU230834B1 publication Critical patent/HU230834B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Atalálmány tárgya gasztrőintesztinális lipázinhibitőrők felhasználásaII. típűsú diabétesz mellitűs kezelésére vagy megelőzésére alkalmasőrális gyógyászati készítmények előállítására. Atalálmány tővábbá afentiek szerint előállítőtt gyógyászati készítményekre vőnatkőzik. ŕ
HU0001014A 1997-02-05 1998-01-29 Tetrahidrolipsztatin felhasználása HU230834B1 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3738397P 1997-02-05 1997-02-05
US60/037,383 1997-02-05
PCT/EP1998/000468 WO1998034630A1 (en) 1997-02-05 1998-01-29 Use of gastrointestinal lipase inhibitors

Publications (3)

Publication Number Publication Date
HUP0001014A2 true HUP0001014A2 (hu) 2000-08-28
HUP0001014A3 HUP0001014A3 (en) 2000-12-28
HU230834B1 HU230834B1 (hu) 2018-07-30

Family

ID=21894047

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0001014A HU230834B1 (hu) 1997-02-05 1998-01-29 Tetrahidrolipsztatin felhasználása

Country Status (28)

Country Link
US (1) US6147108A (hu)
EP (1) EP1017408B1 (hu)
JP (1) JP2001509173A (hu)
KR (1) KR100479968B1 (hu)
CN (1) CN1154505C (hu)
AR (1) AR011106A1 (hu)
AT (1) ATE292975T1 (hu)
AU (1) AU740375B2 (hu)
BR (1) BR9807655A (hu)
CA (1) CA2278854C (hu)
CZ (1) CZ295567B6 (hu)
DE (1) DE69829763T2 (hu)
DK (1) DK1017408T3 (hu)
ES (1) ES2239799T3 (hu)
HK (1) HK1025251A1 (hu)
HU (1) HU230834B1 (hu)
ID (1) ID22650A (hu)
IL (1) IL131007A0 (hu)
ME (1) ME00578A (hu)
NO (1) NO324452B1 (hu)
NZ (1) NZ336755A (hu)
PL (1) PL191222B1 (hu)
PT (1) PT1017408E (hu)
RU (1) RU2201272C2 (hu)
TR (1) TR199901853T2 (hu)
WO (1) WO1998034630A1 (hu)
YU (1) YU34199A (hu)
ZA (1) ZA98753B (hu)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998034630A1 (en) * 1997-02-05 1998-08-13 F.Hoffmann-La Roche Ag Use of gastrointestinal lipase inhibitors
AR025587A1 (es) * 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones en dispersion que contienen inhibidores de lipasa
AR025609A1 (es) 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones lipidas solidas
ES2324280T3 (es) 2000-03-14 2009-08-04 Unilever N.V. Dominios variables de la cadena pesada de anticuerpos frente a lipasas dieteticas humanas y sus usos.
US6828297B2 (en) * 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US9174176B2 (en) 2003-01-09 2015-11-03 Disperse Systems, Inc. Ultrasonic dispersion apparatus, system, and method
US7510849B2 (en) * 2004-01-29 2009-03-31 Glucolight Corporation OCT based method for diagnosis and therapy
EP2626368B1 (en) 2004-07-19 2016-12-21 Biocon Limited Insulin-oligomer conjugates, formulations and uses thereof
US8036727B2 (en) 2004-08-11 2011-10-11 Glt Acquisition Corp. Methods for noninvasively measuring analyte levels in a subject
US7254429B2 (en) 2004-08-11 2007-08-07 Glucolight Corporation Method and apparatus for monitoring glucose levels in a biological tissue
US7822452B2 (en) 2004-08-11 2010-10-26 Glt Acquisition Corp. Method for data reduction and calibration of an OCT-based blood glucose monitor
US8217025B2 (en) * 2006-11-17 2012-07-10 Harbor Therapeutics, Inc. Drug screening and treatment methods
PL2036575T3 (pl) * 2007-09-12 2011-02-28 Mader S R L Kompozycje farmaceutyczne do stosowania doustnie w leczeniu pacjentów dotkniętych otyłością
US20100317642A1 (en) * 2007-10-15 2010-12-16 Inventis Dds Pvt Limited Pharmaceutical composition of orlistat
BRPI0818004B8 (pt) 2007-10-16 2021-05-25 Biocon Ltd composição farmacêutica sólida administrável por via oral e o processo da mesma.
US8768423B2 (en) 2008-03-04 2014-07-01 Glt Acquisition Corp. Multispot monitoring for use in optical coherence tomography
WO2010042499A1 (en) * 2008-10-06 2010-04-15 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms
FR3017536B1 (fr) * 2014-02-18 2017-05-26 Univ La Rochelle Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase
WO2017161043A1 (en) 2016-03-16 2017-09-21 The J. David Gladstone Institutes Methods and compositions for treating obesity and/or diabetes and for identifying candidate treatment agents
US20190022061A1 (en) * 2017-07-21 2019-01-24 Kieu Hoang Statins (Atorvastatin) can lower blood sugar level in diabetic

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
CA1328881C (en) * 1984-12-21 1994-04-26 Pierre Barbier Process for the manufacture of oxetanones
CA1270837A (en) * 1984-12-21 1990-06-26 Hoffmann-La Roche Limited Oxetanones
CA2035972C (en) * 1990-02-23 2006-07-11 Martin Karpf Process for the preparation of oxetanones
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
US5130333A (en) * 1990-10-19 1992-07-14 E. R. Squibb & Sons, Inc. Method for treating type II diabetes employing a cholesterol lowering drug
US5190970A (en) * 1990-10-19 1993-03-02 E. R. Squibb & Sons, Inc. Method for preventing onset of or treating Type II diabetes employing a cholesterol lowering drug alone or in combination with an ace inhibitor
US5345056A (en) * 1991-12-12 1994-09-06 Motorola, Inc. Plasma based soldering by indirect heating
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
CA2128044C (en) * 1993-08-05 2007-02-20 Klaus-Dieter Bremer Pharmaceutical compositions comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor
JP3532999B2 (ja) * 1995-03-24 2004-05-31 株式会社ロッテ 新規なタンニン類およびこれを有効成分とするリパーゼ阻害剤
JPH09227398A (ja) * 1996-02-20 1997-09-02 Zeria Pharmaceut Co Ltd 抗肥満剤
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
WO1998034630A1 (en) * 1997-02-05 1998-08-13 F.Hoffmann-La Roche Ag Use of gastrointestinal lipase inhibitors

Also Published As

Publication number Publication date
EP1017408A1 (en) 2000-07-12
TR199901853T2 (xx) 1999-12-21
NZ336755A (en) 2001-06-29
YU34199A (sh) 2002-08-12
AR011106A1 (es) 2000-08-02
AU6616998A (en) 1998-08-26
US6147108A (en) 2000-11-14
ME00578A (en) 2011-12-20
PT1017408E (pt) 2005-07-29
IL131007A0 (en) 2001-01-28
HUP0001014A3 (en) 2000-12-28
DE69829763D1 (de) 2005-05-19
KR20000070733A (ko) 2000-11-25
PL334975A1 (en) 2000-03-27
CN1154505C (zh) 2004-06-23
EP1017408B1 (en) 2005-04-13
ATE292975T1 (de) 2005-04-15
NO324452B1 (no) 2007-10-22
JP2001509173A (ja) 2001-07-10
HU230834B1 (hu) 2018-07-30
ES2239799T3 (es) 2005-10-01
CA2278854C (en) 2014-03-04
BR9807655A (pt) 2000-02-15
DK1017408T3 (da) 2005-08-01
CZ295567B6 (cs) 2005-08-17
KR100479968B1 (ko) 2005-03-30
ZA98753B (en) 1998-08-05
NO993717L (no) 1999-10-04
RU2201272C2 (ru) 2003-03-27
WO1998034630A1 (en) 1998-08-13
HK1025251A1 (en) 2000-11-10
DE69829763T2 (de) 2006-04-13
PL191222B1 (pl) 2006-03-31
CZ265199A3 (cs) 2000-02-16
CA2278854A1 (en) 1998-08-13
CN1246798A (zh) 2000-03-08
NO993717D0 (no) 1999-07-30
ID22650A (id) 1999-12-02
AU740375B2 (en) 2001-11-01

Similar Documents

Publication Publication Date Title
HUP0001014A2 (hu) Gasztrointesztinális lipáz inhibitorok felhasználása
ATE326867T1 (de) Freie aminosäure enthaltende zusammensetzung
EE03969B1 (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
FI964681A0 (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
HUP9902105A2 (hu) Angiosztatikus dipeptideket tartalmazó gyógyászati készítmények és ezek alkalmazása
IL119989A0 (en) Pharmaceutical compositions for oral treatment of multiple sclerosis
FI925787A0 (fi) Proteolytiska enzymers sackarinderivatinhibitorer
MX9709238A (es) Formulaciones farmaceuticas y de dieta para la profilaxis y tratamiento de trastornos gastrointestinales.
PT705100E (pt) Guanidinas substituidas terapeuticas
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
ES2173858T3 (es) Analogos de huperzina a.
HUP0004544A2 (hu) Angiotenzin-átalakító enzim inhibitora és diuretikum kombinációjának alkalmazása mikrokeringési rendellenességek kezelésére szolgáló gyógyászati készítmény előállítására
ES2162110T3 (es) Derivados de la quinolina antimalaria.
AU4011300A (en) Compositions and methods for the treatment of immune related diseases
DE69805305T2 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
HUP9802423A2 (hu) Hiperproliferatív megbetegedések kombinált gyógyászati kezelése
HUP9901353A2 (hu) ACE-inhibitorok alkalmazása diszpepsziás tünetek kezelésére alkalmas gyógyszerkészítmény előállítására
ATE223721T1 (de) Edelfosin zur behandlung von hirntumoren
IL111805A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of aphthae
NO993627L (no) Anvendelse av en forbindelse for fremstilling av et legemiddel
DK0869785T3 (da) 4-Hydroxycoumarin-3-carboxyamider til behandling af ikke-insulinafhængig diabetes mellitus
ID20165A (id) Penggunaan asam 2-(3,4-dimetoksisinamoil)aminobenzoat untuk pembuatan obat untuk pengobatan atau pencegahan restenosis
AU7079300A (en) Compositions and methods for the treatment of immune related diseases
ATE211914T1 (de) Wismuth enthaltende zusammensetzungen zur verhütung und behandlung gastrointestinaler beschwerden
NO871676L (no) Fremgangsmaate for enzymatisk behandling av xantangummi.

Legal Events

Date Code Title Description
FH91 Appointment of a representative

Free format text: FORMER REPRESENTATIVE(S): DR. TOTH-URBAN LASZLO ES DR. JALSOVSZKY GYOERGYNE UEGYVEDEK, HU

Representative=s name: DR. JALSOVSZKY GYOERGYNE ES DR. MISKOLCZI MARI, HU

FH92 Termination of representative

Representative=s name: DR. TOTH-URBAN LASZLO ES DR. JALSOVSZKY GYOERG, HU